低密度脂蛋白在系统性红斑狼疮相关早期血管老化中的作用
研究比较45例SLE患者与37例健康对照的血浆LDL亚组分,发现SLE患者L5百分比增加3.4倍,且与血压、颈动脉IMT、脉搏波速度及CD16+单核细胞和CX3CL1水平正相关;动物与体外实验提示L5及LPC/PAF可促进血管老化与单核细胞黏附。
要点
- SLE患者L5亚组分升高,与早期血管老化指标正相关。
- SLE-LDL及L5中LPC和PAF水平升高,可诱导内皮功能障碍。
- L5而非总LDL浓度可能促进SLE早发动脉粥样硬化。
核心结论
- SLE患者血浆L5百分比升高而非总LDL浓度,可能促进早期血管老化并导致早发动脉粥样硬化。
研究设计与样本
- 研究纳入45例SLE患者和37例正常健康对照,将血浆LDL色谱分为5个亚组分(L1-L5)并分析组成。
- 评估亚组分水平与早期血管老化指标的相关性,并用体外实验和apoE-/-小鼠实验探索脂质介导内皮功能障碍的机制。
主要发现
- SLE患者血浆L5百分比较正常对照增加3.4倍。
- SLE-L5百分比与平均血压(r=0.27,P=0.04)、右颈动脉IMT(r=0.4,P=0.004)、左颈动脉IMT(r=0.36,P=0.01)、脉搏波速度(r=0.29,P=0.04)、CD16+单核细胞(r=0.35,P=0.004)及CX3CL1(r=0.43,P<0.001)正相关。
- SLE-LDL及SLE-L5血浆亚组分中溶血磷脂酰胆碱(LPC)和血小板活化因子(PAF)水平升高。
- 向年轻雄性apoE-/-小鼠注射SLE-LDL、SLE-L5或LPC可增加血浆CX3CL1、主动脉脂纹面积、主动脉血管老化及巨噬细胞浸润,而注射N-LDL或SLE-L1影响 negligible(每组n=3-8只小鼠)。
- 体外实验中,SLE-L5脂质提取物诱导人单核细胞CX3CR1和CD16表达增加,合成PAF和LPC有类似效应;SLE-LDL和SLE-L5脂质提取物诱导CX3CL1表达并增强单核-内皮细胞黏附。
临床怎么用
- 在SLE患者中,除总LDL浓度外,可关注L5亚组分及其与血压、颈动脉IMT、脉搏波速度等血管老化指标的关联。
- L5相关LPC/PAF及CX3CL1-CX3CR1轴可能作为评估SLE早发动脉粥样硬化风险的潜在靶点。
局限性
- 研究样本量有限(SLE患者45例、对照37例,动物实验每组n=3-8只),结果需更大规模研究验证。
- L5促进早期血管老化的具体临床阈值和干预价值尚未明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients with systemic lupus erythematosus (SLE) often have atherosclerotic complications at a young age but normal low-density lipoprotein (LDL) levels. This study was undertaken to investigate the role of LDL composition in promoting early vascular aging in SLE patients. METHODS: Plasma LDL from 45 SLE patients (SLE-LDL) and from 37 normal healthy controls (N-LDL) was chromatographically divided into 5 subfractions (L1-L5), and the subfraction composition was analyzed. Correlations between subfraction levels and signs of early vascular aging were assessed. Mechanisms of lipid-mediated endothelial dysfunction were explored using in vitro assays and experiments in apoE-/- mice. RESULTS: The L5 percentage was increased 3.4 times in the plasma of SLE patients compared with normal controls. This increased percentage of SLE-L5 was positively correlated with the mean blood pressure (r = 0.27, P = 0.04), carotid intima-media thickness (IMT) (right carotid IMT, r = 0.4, P = 0.004; left carotid IMT, r = 0.36, P = 0.01), pulse wave velocity (r = 0.29, P = 0.04), and blood levels of CD16+ monocytes (r = 0.35, P = 0.004) and CX3CL1 cytokines (r = 0.43, P < 0.001) in SLE patients. Matrix-assisted laser desorption ionization-time-of-flight mass spectrometry analysis revealed that plasma levels of lysophosphatidylcholine (LPC) and platelet-activating factor (PAF) were increased in SLE-LDL and in the SLE-L5 plasma subfraction. Injecting SLE-LDL, SLE-L5, or LPC into young, male apoE-/- mice caused increases in plasma CX3CL1 levels, aortic fatty-streak areas, aortic vascular aging, and macrophage infiltration into the aortic wall, whereas injection of N-LDL or SLE-L1 had negligible effects (n = 3-8 mice per group). In vitro, SLE-L5 lipid extracts induced increases in CX3CR1 and CD16 expression in human monocytes; synthetic PAF and LPC had similar effects. Furthermore, lipid extracts of SLE-LDL and SLE-L5 induced the expression of CX3CL1 and enhanced monocyte-endothelial cell adhesion in assays with bovine aortic endothelial cells. CONCLUSION: An increase in plasma L5 levels, not total LDL concentration, may promote early vascular aging in SLE patients, leading to premature atherosclerosis.
引用
- Chan HC, Chan HC, Liang CJ, et al. Role of Low-Density Lipoprotein in Early Vascular Aging Associated With Systemic Lupus Erythematosus. Arthritis Rheumatol. 2020. PMID: 31994323. doi:10.1002/art.41213
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。